Nemesis Bioscience

Developer of therapeutics to reverse microbial resistance to antibiotics

placeCambridge, England, United Kingdom calendar_todayFounded 2014 groups8 employees language nemesisbio.com

Registered entities

Innovation

5 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 131 times.

YearFilings
20143
20152
20161
20172
20182
20191
20201
20212
20221

Investor mix

39 investors on record; lead investors include UK Innovation Science & Seed Fund, Shionogi, Coastal International, Wren Capital.

Investor typeCountShare
Venture capital38%
Private equity13%
Accelerator & incubator13%
Other / undisclosed3487%
Coming soon